Ramdevbaba Solvent IPO Details: Price, Dates & Financials
The Ramdevbaba Solvent IPO GMP strength score is 7.3 out of 10, which the dashboard rates as Good. The Ramdevbaba Solvent IPO valuation is tagged Good. The Ramdevbaba Solvent IPO QIB category is reserved for 47.35% of the offer. The Ramdevbaba Solvent IPO NII/HNI category is reserved for 14.2% of the offer. The Ramdevbaba Solvent IPO Retail (RII) category is reserved for 33.14% of the offer. Live subscription numbers for the Ramdevbaba Solvent IPO are not yet available, and amounts are calculated at the upper price band of ₹85.
| Category | Sub (x) | Offered | Bid For |
|---|---|---|---|
| QIB | — | 2,800,000 (47%) | — |
| NII / HNI | — | 840,000 (14%) | — |
| Retail (RII) | — | 1,960,000 (33%) | — |
| Market Maker | — | 313,600 (5%) | — |
| Total | — | 5,913,600 (100%) | — |
* Amount calculated at upper price band (₹85) · ** Total includes all investor categories
- 1 Initiation of Refund 22 Apr 2024
- 2 Credit of Shares to Demat 22 Apr 2024
- Retail allocation is good at 33% of the total offering.
- HNI/NII demand is good at 14%.
- Institutional (QIB) interest is strong at 47%.
- The IPO P/E of 17x reflects a good valuation relative to typical market ranges.
- Pre-issue EPS of ₹8 compares to post-issue EPS of ₹5 after dilution.
This IPO shows moderate investor interest. Review financial details and compare valuation with industry peers before investing.
GMP and IPO data are unofficial and for information only — not investment advice. Read the full disclaimer.